Thermo Fisher Scientific (TMO) FCF Margin (2009 - 2026)

Thermo Fisher Scientific has disclosed FCF Margin across 18 years of filings, most recently posting 7.41% for Q1 2026.

• Quarterly FCF Margin rose 393.0% year-over-year to 7.41% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.93% (down 74.0% YoY) and the FY2025 annual result came in at 14.12%, down 282.0% from the prior year.
• FCF Margin eased to 7.41% in Q1 2026, from 24.49% in the prior quarter.
• Over five years, FCF Margin peaked at 30.48% in Q4 2023 and troughed at 2.53% in Q2 2023.
• A 5-year average of 14.98% and a median of 13.22% in 2022 frame the typical range for FCF Margin.
• Annual changes were most pronounced in 2022 — FCF Margin jumped 1046 bps — and 2023, when it plunged 1069 bps.
• Tracing TMO's FCF Margin over 5 years: stood at 25.65% in 2022, then grew by 19 bps to 30.48% in 2023, then slipped by 19 bps to 24.66% in 2024, then slipped by 1 bps to 24.49% in 2025, then slumped by 70 bps to 7.41% in 2026.
• Business Quant data shows TMO's FCF Margin at 7.41% in Q1 2026, 24.49% in Q4 2025, and 16.5% in Q3 2025.